Cytogenetic and molecular cytogenetic evidence of recurrent 8q24.1 loss in osteochondroma

Cancer Genetics and Cytogenetics

Volumn 137, Issue 2, 2002, Pages 102-107

  Feely, Michael G ^a   Boehm, Amber K ^a   Bridge, Robert S ^a   Krallman, Pamela A ^a   Neff, James R ^a   Nelson, Marilu ^a   Bridge, Julia A ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER RECURRENCE; CENTROMERE; CHILD; CHROMOSOME 8Q; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHROMOSOME LOSS; CLINICAL ARTICLE; CONTROLLED STUDY; COSMID; CYTOGENETICS; FEMALE; GENE PROBE; GENETIC DISORDER; HUMAN; HUMAN TISSUE; KARYOTYPING; MALE; MOLECULAR GENETICS; OSTEOCHONDROMA; PRIORITY JOURNAL;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 8; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MALE; OSTEOCHONDROMA;

EID: 0036752209     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(02)00557-5     Document Type: Article

References (29)

1. nd Ed:1991;W.B. Saunders Co. Philadelphia. 253-68.
2. Sandberg A.A., Bridge J.A. The cytogenetics of bone and soft tissue tumors. 1994;RG Landes Co. Austin. 313-41.
3. Lüdecke H.J., Johnson C., Wagner M.J., Wells D.E., Turleau C., Tommerup N., Latos-Bielenska A., Sandig K.R., Meinecke P., Zabel B., Horsthemke B. Molecular definition of the shortest region of deletion overlap in the Langer-Giedion syndrome. Am J Hum Genet. 49:1991;1197-1206.
4. Parrish J.E., Wagner M.J., Hecht J.T., Scott C.I., Wells D.E. Molecular analysis of overlapping chromosomal deletions in patients with Langer-Giedion syndrome. Genomics. 11:1991;54-61.
5. Hou J., Parrish J., Lüdecke H.J., Saptru M., Wang Y., Chen W., Hill A., Sigel-Bartelt J., Northrup H., Elder F.F., Wijsman E., Hecht J.T., Wells D., Wagner M.J. A 4-megabase YAC contig that spans the Langer-Giedion syndrome region on human chromosome 8q24.1. Use in refining the location of the trichorhinophalangeal syndrome and multiple exostoses genes (TRPS1 and EXT1) Genomics. 29:1995;87-97.
6. Bartsch O., Wuyts W., Van Hul W., Hecht J.T., Meinecke P., Hogue D., Werner W., Zabel B., Hinkel G.K., Powell C.M., Shaffer L.G., Willems P.J. Delineation of a contiguous gene syndrome with multiple exostoses, enlarged parietal foramina, craniofacial dysostoses and mental retardation, caused by deletions on the short arm of chromosome 11. Am J Hum Genet. 58:1996;734-742.
7. Potocki L., Shaffer L.G. Interstitial deletion of 11 (p11.2p12). a newly described contiguous gene deletion syndrome involving the gene for hereditary multiple exostoses (EXT2) Am J Med Genet. 62:1996;319-325.
8. Wu Y.Z., Badano J.L., McCaskill C., Vogel H., Potocki L., Shaffer L.G. Haploinsufficiency of ALX4 as a potential cause of parietal foramina in the 11p11.2 contiguous gene-deletion syndrome. Am J Hum Genet. 67:2000;1327-1332.
9. Schmale G.A., Conrad E.U., Raskind W.H. The natural history of hereditary multiple exostoses. J Bone Joint Surg. 76A:1994;986-992.
10. Cook A., Raskind W., Blanton S.H., Pauli R.M., Gregg R.G., Frandomano C.A., Puffenberger E., Conrad E.U., Schmale G., Schellenberg G., Wijsman E., Hecht J.T., Wells D., Wagner M.J. Genetic heterogeneity in families with hereditary multiple exostoses. Am J Hum Genet. 53:1993;71-79.
11. Wu Y.Q., Heutink P., de Vries B.B., Sanduijl L.A., van den Ouweland A.M., Niermeijer M.F., Galjaard H., Reyniers E., Willems P.J., Halley D.J. Assignment of a second locus for multiple exostoses to the pericentric region of chromosome 11. Hum Mol Genet. 3:1994;167-171.
12. Le Merrer M., Legeai-Mallet L., Jeannin P.M., Horsthemke B., Schinzel A., Plauchu H., Toutain A., Achard F., Munnich A., Maroteaux P. A gene for hereditary multiple exostoses maps to chromosome 19p. Hum Mol Genet. 3:1994;717-722.
13. Bridge J.A. Current concepts review. Cytogenetic and molecular cytogenetic techniques in orthopaedic surgery. J Bone Joint Surg. 75A:1993;606-614.
14. Bridge J.A., Bhatia P.S., Anderson J.R., Neff J.R. Biologic and clinical significance of cytogenetic and molecular cytogenetic abnormalities in benign and malignant cartilaginous lesions. Cancer Genet Cytogenet. 69:1993;79-90.
15. Mertens F., Rydholm A., Kreicbergs A., Willen H., Jonsson K., Heim S., Mitelman F., Mandahl N. Loss of chromosome band 8q24 in sporadic osteocartilaginous exostoses. Genes Chromosomes Cancer. 9:1994;8-12.
16. Bridge JA, Nelson M, Orndal C. Bhatia P, Neff JR. Clonal karyotypic abnormalities of the hereditary multiple exostoses chromosomal loci 8q24.1 (EXT1) and 11p11-12 (EXT2) in patients with sporadic and hereditary osteochondromas. Cancer 1998;82:1657-63.
17. ISCN. An International System for Human Cytogenetic Nomenclature. F Mitelman, ed. S. Karger, Basel, 1995.
18. Bridge J.A., Fidler M.E., Neff J.R., Degenhardt J., Wang M., Walker C., Dorfman H.D., Baker K.S., Seemayer T.A. Adamantinoma-like Ewing's sarcoma. genomic confirmation, phenotypic drift Am J Surg Pathol. 23:1999;159-165.
19. Krooth R.S., Macklin M.T., Kilbish T.F. Diaphyseal aclasis (multiple exostoses) on Guam. Am J Hum Genet. 13:1961;340-347.
20. Swarts S.J., Neff J.R., Nelson M., Johansson S., Bridge J.A. Chromosomal abnormalities in low grade chondrosarcoma and a review of the literature. Cancer Genet Cytogenet. 98:1997;126-130.
21. Ptaszynski K., Ramesh K.H., Cannizzaro L.A. Clonal chromosome aberrations with monosomy of chromosome 8 in a case of grade III chondrosarcoma. Cancer Genet Cytogenet. 97:1997;60-63.
22. Sawyer J.R., Swanson L.M., Lukacs J.L., Nicholas R.W., North P.E., Thomas J.R. Evidence of an association between 6q13-21 chromosomal aberrations and locally aggressive behavior in patients with cartilaginous tumors. Cancer. 82:1998;474-483.
23. Safar A., Nelson M., Neff J.R., Maale G.E., Bayani J., Squire J., Bridge J.A. Recurrent anomalies of 6q25 in chondromyxoid fibroma. Hum Pathol. 31:2000;306-311.
24. Gunawan B., Weber Bergmann F., Wildberger J., Niethard F.U., Fuzesi L. Clonal chromosome abnormalities in enchondromas and chondrosarcomas. Cancer Genet Cytogenet. 120:2000;127-130.
25. Bovee J.V.M.G., Sciot R., Dal Cin P., Debiec-Rychter M., van Zelderen-Bhola S.L., Cornelisse C.J., Hogendoorn P.C.W. Chromosome 9 alterations and trisomy 22 characterise central chondrosarcoma; a cytogenetic and DNA flow cytometric analysis of chondrosarcoma subtypes. Diagn Mol Pathol. 10:2001;229-235.
26. Bovee J.V.M.G., Cleton-Jansen A., Wuyts W., Caethoven G., Taminiau A.H.M., Bakker E., Van Hul W., Cornelisse C.J., Hogendoorn P.C.W. EXT-mutation analysis and loss of heterozygosity in sporadic and hereditary osteochondromas and secondary chondrosarcomas. Am J Hum Genet. 65:1999;689-698.
27. Legeai-Mallet L., Margaritte-Jeannin P., Lemdani M., Le Merrer M., Plauchu H., Maroteaux P., Munnich A., Clerget-Darpoux F. An extension of the admixture test for the study of genetic heterogeneity in hereditary multiple exostoses. Hum Genet. 99:1997;298-302.
28. Raskind W.H., Conrad E.U., Matsushita M., Wijsman E.M., Wells D.E., Chapman N., Sandell L.J., Wagner M., Houck J. Evaluation of locus heterogeneity and EXT1 mutations in 34 families with hereditary multiple exostoses. Hum Mutat. 11:1998;231-239.
29. Carroll K.L., Yandow S.M., Ward K., Carey J.C. Clinical correlation to genetic variations of hereditary exostosis. J Pediatr Orthop. 19:1999;785-791.